| [1] Tsuda K. Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension[J]. Int J Hypertens,2012,2012:474870.[2] Ribeiro N,PanizzaHDN,Santos KMD,et al. Salt-induced sympathoexcitation involves vasopressin V1a receptor activation in the paraventricular nucleus of the hypothalamus[J]. Am J Physiol Regul Integr Comp Physiol,2015,309(11):R1369-1379.[3] Erdos B,Clifton RR,Liu M,et al. Novel mechanism within the paraventricular nucleus reduces both blood pressure and hypothalamic pituitary-adrenal axis responses to acute stress[J]. Am J Physiol Heart Circ Physiol,2015,309(4):H634-645.[4] Thompson TB,Cook RW,Chapman SC,et al. Beta A versus beta B:is it merely a matter of expression?[J]. Mol Cell Endocrinol,2004,225(1/2):9-17.[5] Wijayarathna R,de Kretser DM. Activins in reproductive biology and beyond[J]. Hum Reprod Update, 2016,22(3).doi:10.1093/humupd/dmv058.[6] Fang L,Wang YN,Cui XL,et al. The role and mechanism of action of activin A in neurite outgrowth of chicken embryonic dorsal root ganglia[J]. J Cell Sci,2012,125(Pt 6):1500-1507.[7] Ge J,Wang Y,Liu H,et al. Activin A maintains cerebral cortex neuronal survival and increases voltage-gated Na+ neuronal current[J]. Neural Regen Res,2010,5(19):1464-1469.[8] Liu HY,Wang YN,Ge JY,et al. Localisation and role of activin receptor-interacting protein 1 in mouse brain[J]. J Neuroendocrinol,2013,25(1):87-95.[9] Zhang Y,Shan S,Wang J,et al. Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathway[J]. Mol Cell Biochem,2016,413(1/2):109-118.[10] Yndestad A,Larsen KO,Oie E,et al. Elevated levels of activin A in clinical and experimental pulmonary hypertension[J]. J Appl Physiol (1985), 2009,106(4):1356-1364.[11] Williamson RD,O'Keeffe GW,Kenny LC. Activin signalling and pre-eclampsia:from genetic risk to pre-symptomatic biomarker[J]. Cytokine,2015,71(2):360-365.[12] Matzuk MM,Kumar TR,Vassalli A,et al. Functional analysis of activins during mammalian development[J]. Nature,1995,374(6520):354-356.[13] Matzuk MM,Kumar TR,Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type Ⅱ[J]. Nature,1995,374(6520):356-360.[14] Matsuki K,Hathaway CK,Lawrence MG,et al. The role of transforming growth factor β1 in the regulation of blood pressure[J]. Curr Hypertens Rev,2014,10(4):223-238.[15] Lavoie P,Robitaille G,Agharazii M,et al. Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats[J]. J Hypertens,2005,23(10):1895-1903.[16] Kurisaki A,Inoue I,Kurisaki K,et al. Activin induces long-lasting N-methyl-D-aspartate receptor activation via scaffolding PDZ protein activin receptor interacting protein 1[J].Neuroscience,2008,151(4):1225-1235.[17] Marino FE,Risbridger G,Gold E. The therapeutic potential of blocking the activin signalling pathway[J]. Cytokine Growth Factor Rev,2013,24(5):477-484. |
